Results 121 to 130 of about 41,551 (306)

New Perspectives in the Studies on Endocannabinoid and Cannabis: Cannabinoid Receptors and Schizophrenia

open access: yesJournal of Pharmacological Sciences, 2004
Cannabis consumption may induce psychotic states in normal individuals, worsen psychotic symptoms of schizophrenic patients, and may facilitate precipitation of schizophrenia in vulnerable individuals.
Hiroshi Ujike, Yukitaka Morita
doaj   +1 more source

Cardio-renal effects of chronic administration with CB2 agonist AM1241 and CB2 antagonist AM630 in rats with diet induced obesity

open access: yes, 2013
It is widely recognised that obesity elicits a number of comorbidities including heart and kidney disease. The progression of these diseases is frequently exacerbated by other clinical factors associated with obesity such as hypertension and metabolic ...
Mathai, Michael L.   +5 more
core  

The evolution of Australian cannabis policies, 1967 to 2024

open access: yesAddiction, EarlyView.
Abstract Aim To describe the outcomes of cannabis policy debates in Australia from 1967 to 2024. Methods We searched popular media, public reports, parliamentary inquiries and policy documents on cannabis in Australia since the 1960s and examined peer reviewed papers, national survey data and police records of cannabis‐related arrests.
Wayne D. Hall   +3 more
wiley   +1 more source

The endocannabinoid system and stroke: A focused review

open access: yesBrain Circulation, 2019
Stroke is an important cause of morbidity and mortality worldwide. Development of novel neuroprotectants is of paramount importance. This review seeks to summarize the recent evidence for the role of the endocannabinoid signaling system in stroke ...
Bradley Kolb   +3 more
doaj   +1 more source

The regulation of endocannabinoids after neuronal damage and the neuroprotective impact of GPR55 in organotypic hippocampal slice cultures

open access: yes, 2013
Endocannabinoids (eCB) are signaling lipids and became known for their importance in the central nervous system as well as in immune defense. Beneficial effects of eCB are shown in processes of excitotoxic lesion, secondary damage and neuronal plasticity
Kallendrusch, Sonja
core  

The psychometric properties of validated tools to assess cannabis use disorder: A systematic review and meta‐analysis

open access: yesAddiction, EarlyView.
Abstract Aims To systematically review the evidence on the psychometric performance and accuracy of screening or diagnostic tools for cannabis use disorder. Method Systematic review and meta‐analysis which included studies conducted in clinical settings, schools, universities, community settings and population‐based surveys in multiple countries and ...
Janni Leung   +8 more
wiley   +1 more source

#NoIDVape: A content analysis of illicit vape messaging in young people's information sources

open access: yesAddiction, EarlyView.
Abstract Background and aims In recent years, the increased prevalence of youth vaping in the United Kingdom (UK) may have coincided with a proliferation in the use of ‘illicit’ (unregulated) vapes. Media or educational content about illicit vaping aimed at young people is scarce and poorly understood.
Eleanor Bray   +5 more
wiley   +1 more source

Experimental Cannabinoid Receptor 2 Activation in Lipopolysaccharide-Induced Interstitial Cystitis in Mice

open access: yes, 2020
Interstitial cystitis (IC) is a chronic pain disorder of the urinary bladder that causes symptoms of persistent pelvic pain, nocturia, and dysuria with no curative treatment.
Berger, Geraint
core  

Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats.

open access: yes, 2008
OBJECTIVE Blockade of the CB1 receptor is one of the promising strategies for the treatment of obesity. Although antagonists suppress food intake and reduce body weight, the role of central versus peripheral CB1 activation on weight loss and related ...
Nogueiras, Ruben   +13 more
core   +1 more source

Characteristics of deaths due to drug‐related causes among individuals recently released from prison in the United Kingdom, 1997–2025

open access: yesAddiction, EarlyView.
Abstract Background and aims There has been an extensive literature describing the elevated risk of drug‐related death following an individual's release from prison; however, few previous studies have reported nationally representative samples or provided granular detail as to which individual drugs were deemed implicated in death.
Emmert Roberts   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy